EMMA International Consulting Group, Inc. Launches Competitive Intelligence Services for Life Sciences
EMMA International introduces its new Competitive Intelligence service, helping life sciences companies turn market insights into strategic advantage.
Providing Strategic Insight to Outmaneuver Competitors and Accelerate Market Success
Competitive intelligence in life sciences turns information into strategic advantage. Clients don’t just need data—they need analysis, foresight, and context they can act on. That’s where we excel.”
BIRMINGHAM, MI, UNITED STATES, August 20, 2025 /EINPresswire.com/ -- E.M.M.A. International Consulting Group, Inc. (EMMA International), a leading global consulting firm specializing in regulatory compliance, quality systems, and operational excellence, proudly announces the launch of its new Competitive Intelligence (CI) Services. This comprehensive offering is designed to help life science companies anticipate competitive moves, mitigate risks, and strengthen supply chain resilience through domestic manufacturing and reshoring services.— Kira Jabri, COO, EMMA International
In a global market defined by rapid innovation, shifting regulations, and intense competition, timely and actionable intelligence is essential to staying ahead. EMMA International is responding with a full-suite solution tailored specifically to the complex needs of pharmaceutical, biotech, medical device, and diagnostics companies.
“Competitive intelligence in the life sciences is about transforming information into strategic advantage,” said Kira Jabri, COO of EMMA International. “Our clients don’t just need data—they need analysis, foresight, and context they can act on. That’s where we excel.”
The new Competitive Intelligence Services include:
• Regulatory Intelligence – Global regulatory landscape mapping, competitor filing analysis, and inspection/enforcement monitoring.
• Clinical & Pipeline Intelligence – Clinical trial benchmarking, pipeline tracking, and innovation monitoring.
• Market & Commercial Intelligence – Competitive landscape assessments, product launch surveillance, and key opinion leader (KOL) mapping.
• Strategic Business Intelligence – M&A and partnership diligence, technology transfer analysis, and early warning systems for emerging risks.
With a team comprised of former FDA reviewers, clinical operations experts, data scientists, and global compliance consultants, EMMA International provides clients with confidential, tailored intelligence to support decisions from product development through commercialization.
Whether preparing for a new product launch, responding to evolving regulations, or assessing market entry strategies, EMMA International delivers the clarity and foresight life science companies need to stay ahead.
About EMMA International
EMMA International is a leading global consulting firm for the medical device, pharmaceutical, biotechnology, combination products, and diagnostics industries. With a focus on quality, regulatory and compliance services, EMMA International helps ensure your products advance seamlessly from concept to approval.
Shelby Whitelaw
EMMA International Consulting Group
+1 248-987-4497
shelby.whitelaw@emmainternational.com
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
X
Competitive Intelligence: The Secret Advantage for Life Science Companies
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
